Substance P in the corneal stroma regulates the severity of herpetic stromal keratitis lesions

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 12, 2011, Pages 8604-8613

  Twardy, Brandon S ^a   Channappanavar, Rudragouda ^a   Suvas, Susmit ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CXCL2 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEUROKININ 1 RECEPTOR; SPANTIDE; SUBSTANCE P; ANALGESIC AGENT; CCL3 PROTEIN, MOUSE; CXCL2 PROTEIN, MOUSE; DRUG DERIVATIVE; PTPRC PROTEIN, MOUSE; TUBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA LESION; CORNEA NEOVASCULARIZATION; CORNEA OPACITY; CORNEA STROMA; DISEASE SEVERITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SLIT LAMP; VIRUS LOAD; ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; DISEASE MODEL; HOSPITALIZATION; IMMUNOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ANALGESICS; ANIMALS; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL3; CHEMOKINE CXCL2; CORNEAL STROMA; DISEASE MODELS, ANIMAL; FEMALE; HERPESVIRUS 1, HUMAN; INTERLEUKIN-6; KERATITIS, HERPETIC; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHILS; RECEPTORS, NEUROKININ-1; SEVERITY OF ILLNESS INDEX; SUBSTANCE P; TUBULIN; VIRAL LOAD;

EID: 84855388865     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8089     Document Type: Article

References (41)

1. Biswas PS, Banerjee K, Kim B, Rouse BT. Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis. J Immunol. 2004;172:3736-3744.
2. Niemialtowski MG, Rouse BT. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J Immunol. 1992;149: 3035-3039.
3. Biswas PS, Rouse BT. Early events in HSV keratitis-setting the stage for a blinding disease. Microbes Infect. 2005;7:799-810.
4. Hendricks RL, Janowicz M, Tumpey TM. Critical role of corneal Langerhans cells in the CD4-but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas. J Immunol. 1992;148:2522-2529.
5. Thomas J, Gangappa S, Kanangat S, Rouse BT. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol. 1997;158:1383-1391.
6. Payan DG. Neuropeptides and inflammation: the role of substance P. Annu Rev Med. 1989;40:341-352.
7. Gonzalez-Rey E, Delgado M. Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders? Trends Pharmacol Sci. 2007;28:482-491.
8. Snijdelaar DG, Dirksen R, Slappendel R, Crul BJ. Substance P. Eur J Pain. 2000;4:121-135.
9. Bost KL. Tachykinin-modulated anti-viral responses. Front Biosci. 2004;9:1994-1998.
10. Nelson DA, Bost KL. Non-neuronal mammalian tachykinin expression. Front Biosci. 2004;9:2166-2176.
11. Tuluc F, Lai JP, Kilpatrick LE, Evans DL, Douglas SD. Neurokinin 1 receptor isoforms and the control of innate immunity. Trends Immunol. 2009;30:271-276.
12. Nakanishi S. Mammalian tachykinin receptors. Annu Rev Neurosci. 1991;14:123-136.
13. Janelsins BM, Mathers AR, Tkacheva OA, et al. Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity. Blood. 2009;113:3017-3026.
14. Ramnath RD, Bhatia M. Substance P treatment stimulates chemokine synthesis in pancreatic acinar cells via the activation of NFkappaB. Am J Physiol Gastrointest Liver Physiol. 2006;291: G1113-G1119.
15. Miller A, Costa M, Furness JB, Chubb IW. Substance P immunoreactive sensory nerves supply the rat iris and cornea. Neurosci Lett. 1981;23:243-249.
16. Keen P, Tullo AB, Blyth WA, Hill TJ. Substance P in the mouse cornea: effects of chemical and surgical denervation. Neurosci Lett. 1982;29:231-235.
17. Spear PG, Roizman B. Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion. J Virol. 1972;9:143-159.
18. Dana MR, Zhu SN, Yamada J. Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea. 1998;17: 403-409.
19. Mensher JH. Corneal nerves. Surv Ophthalmol. 1974;19:1-18.
20. Deshpande S, Banerjee K, Biswas PS, Rouse BT. Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Rev Mol Med. 2004;6:1-14.
21. Lepisto AJ, Frank GM, Hendricks RL. How herpes simplex virus type 1 rescinds corneal privilege. Chem Immunol Allergy. 2007; 92:203-212.
22. Gitter BD, Regoli D, Howbert JJ, Glasebrook AL, Waters DC. Interleukin-6 secretion from human astrocytoma cells induced by substance P. J Neuroimmunol. 1994;51:101-108.
23. Sio SW, Puthia MK, Lu J, Moochhala S, Bhatia M. The neuropeptide substance P is a critical mediator of burn-induced acute lung injury. J Immunol. 2008;180:8333-8341.
24. Hazlett LD, McClellan SA, Barrett RP, Liu J, Zhang Y, Lighvani S. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci. 2007;48:797-807.
25. Fenton RR, Molesworth-Kenyon S, Oakes JE, Lausch RN. Linkage of IL-6 with neutrophil chemoattractant expression in virusinduced ocular inflammation. Invest Ophthalmol Vis Sci. 2002; 43:737-743.
26. Tumpey TM, Cheng H, Cook DN, Smithies O, Oakes JE, Lausch RN. Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis. J Virol. 1998;72: 3705-3710.
27. Divito SJ, Hendricks RL. Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis. Invest Ophthalmol Vis Sci. 2008;49:1488-1495.
28. Babu JS, Thomas J, Kanangat S, Morrison LA, Knipe DM, Rouse BT. Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol. 1996;70:101-107.
29. McClellan SA, Zhang Y, Barrett RP, Hazlett LD. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated. Invest Ophthalmol Vis Sci. 2008;49:1502-1511.
30. Tullo AB, Keen P, Blyth WA, Hill TJ, Easty DL. Corneal sensitivity and substance P in experimental herpes simplex keratitis in mice. Invest Ophthalmol Vis Sci. 1983;24:596-598.
31. Templeton A, Nguyen G, Ash JD, Straub RH, Carr DJ. Chemical sympathectomy increases susceptibility to ocular herpes simplex virus type 1 infection. J Neuroimmunol. 2008;197:37-46.
32. Bowden JJ, Garland AM, Baluk P, et al. Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation. Proc Natl Acad Sci U S A. 1994;91: 8964-8968.
33. Daheshia M, Kanangat S, Rouse BT. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp Eye Res. 1998;67:619-624.
34. Lee S, Zheng M, Kim B, Rouse BT. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest. 2002;110:1105-1111.
35. Mistry SK, Zheng M, Rouse BT, Morris SM Jr. Induction of arginases I and II in cornea during herpes simplex virus infection. Virus Res. 2001;73:177-182.
36. Lambrecht BN, Germonpre PR, Everaert EG, et al. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Iimmunol. 1999;29:3815-3825.
37. Germonpre PR, Bullock GR, Lambrecht BN, et al. Presence of substance P and neurokinin 1 receptors in human sputum macrophages and U-937 cells. Eur Respir J. 1999;14:776-782.
38. Ho WZ, Lai JP, Zhu XH, Uvaydova M, Douglas SD. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol. 1997;159:5654-5660.
39. Hamrah P, Cruzat A, Dastjerdi MH, et al. Corneal sensation and subbasal nerve alterations in patients with herpes simplex keratitis: an in vivo confocal microscopy study. Ophthalmology. 2010;117:1930-1936.
40. Cruzat A, Witkin D, Baniasadi N, et al. Inflammation and the nervous system: the connection in the cornea in patients with infectious keratitis. Invest Ophthalmol Vis Sci. 2011;52:5136-5143.
41. Yu CQ, Zhang M, Matis KI, Kim C, Rosenblatt MI. Vascular endothelial growth factor mediates corneal nerve repair. Invest Ophthalmol Vis Sci. 2008;49:3870-3878.